Suchergebnisse - "Clinical Trial, Phase III"

PubPharm (18.684)

21

Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma : An Exploratory Analysis of AGO-OVAR11/ICON-7

enthalten in: Laboratory investigation; a journal of technical methods and pathology | 2024

von Heublein, S. | Pfisterer, J. | du Bois, A. | +18

22

Efficacy and safety of ivermectin in patients with mild COVID-19 in Japan and Thailand

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2024

von Mikamo, H. | Takahashi, S. | Yamagishi, Y. | +17

23

Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis : A randomized, double-blinded, vehicle-controlled, phase 3 trial

enthalten in: Journal of the American Academy of Dermatology | 2024

von Blauvelt, A. | Draelos, Z. | Stein Gold, L. | +18

24

Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS) : a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Neurology | 2024

von Mercuri, E. | Vilchez, J. | Boespflug-Tanguy, O. | +25

ErratumIn: Lancet Neurol. 2024 Apr 18;:. - PMID 38643778

25

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

enthalten in: The New England journal of medicine | 2024

von Choueiri, T. | Tomczak, P. | Park, S. | +131

26

Deucravacitinib in plaque psoriasis : 2-year safety and efficacy results from the phase III POETYK trials

enthalten in: The British journal of dermatology | 2024

von Lebwohl, M. | Warren, R. | Sofen, H. | +12

CommentIn: Br J Dermatol. 2024 Feb 26;:. - PMID 38407434

27

High-Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults

enthalten in: Influenza and other respiratory viruses | 2024

von Palmu, A. | Pepin, S. | Syrjänen, R. | +7

28

Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis : a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials

enthalten in: The Journal of dermatological treatment | 2024

von Merola, J. | Armstrong, A. | Khattri, S. | +6

29

Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless) : a phase 3, randomised, double-blind, double-dummy, multicentre trial

enthalten in: The Lancet. Neurology | 2024

von Espay, A. | Stocchi, F. | Pahwa, R. | +87

30

Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal : an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial

enthalten in: The Lancet. Global health | 2024

von Song, K. | Chapagain, R. | Tamrakar, D. | +24